
Mucopolysaccharidosis type VI on enzyme replacement therapy since infancy: Six years follow-up of four children
Keywords: Mucopolysaccharidosis; Maroteaux–Lamy syndrome; MPS VI; Glycosaminoglycan (GAG); Enzyme replacement therapy (ERT); N-acetylgalactosamine-4-sulfatase (ASB); Galsulfase; Early treatment